Cargando…

PIK3CG single nucleotide polymorphisms are associated with poor responsiveness to clopidogrel and increased risk of ischemia in patients with coronary heart disease

BACKGROUND: This study explores the associations between PIK3CG single nucleotide polymorphisms (SNPs, rs1129293 and rs17398575) and patient responsiveness to clopidogrel to evaluate the risks of ischemia in patients with coronary heart disease (CHD). METHODS: The study consisted of 513 CHD patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Ke-Cheng, Yu, Shu-Hong, Zhuge, Bao-Zhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6392743/ https://www.ncbi.nlm.nih.gov/pubmed/28885323 http://dx.doi.org/10.1097/MD.0000000000007566

Ejemplares similares

The DNAm levels of CREB5 (cg11301281) were associated with clopidogrel resistance
por: Li, Jiyi, et al.
Publicado: (2022)

Germline biallelic PIK3CG mutations in a multifaceted immunodeficiency with immune dysregulation
por: Thian, Marini, et al.
Publicado: (2020)

Influence of genetic polymorphisms in P2Y12 receptor signaling pathway on antiplatelet response to clopidogrel in coronary heart disease
por: Zhang, Yan-Jiao, et al.
Publicado: (2022)

The Role of Genetic Polymorphism and Other Factors on Clopidogrel Resistance (CR) in an Asian Population with Coronary Heart Disease (CHD)
por: Akkaif, Mohammed Ahmed, et al.
Publicado: (2021)

Single Nucleotide Polymorphism rs17849071 G/T in the PIK3CA Gene Is Inversely Associated with Follicular Thyroid Cancer and PIK3CA Amplification
por: Xing, Jeffrey C., et al.
Publicado: (2012)

Polymorphisms in GP6, PEAR1A, MRVI1, PIK3CG, JMJD1C, and SHH Genes in Patients with Unstable Angina
por: Rudzik, Rafał, et al.
Publicado: (2020)

Associations of PER3 polymorphisms with clopidogrel resistance among Chinese Han people treated with clopidogrel
por: Zheng, Nan, et al.
Publicado: (2021)

A Review of Danshen Combined with Clopidogrel in the Treatment of Coronary Heart Disease
por: Zhang, Zhaojian, et al.
Publicado: (2019)

CD80 DNA methylation and single-nucleotide polymorphism associated with clopidogrel response: a whole-genome DNA methylation analysis in acute coronary syndrome
por: Song, Pei-Yuan, et al.
Publicado: (2023)

Targeting PIK3CG in Combination with Paclitaxel as a Potential Therapeutic Regimen in Claudin-Low Breast Cancer
por: Chang, Jun, et al.
Publicado: (2020)

Relationship between CYP2C19 Polymorphism and Clopidogrel Resistance in Patients with Coronary Heart Disease and Ischemic Stroke in China
por: Chang, Rong, et al.
Publicado: (2022)

CYP2C19 Polymorphism in Ischemic Heart Disease Patients Taking Clopidogrel After Percutaneous Coronary Intervention in Egypt
por: Shawky, Ahmed, et al.
Publicado: (2023)

The impact of cytochrome 450 and Paraoxonase polymorphisms on clopidogrel resistance and major adverse cardiac events in coronary heart disease patients after percutaneous coronary intervention
por: Zhang, Zhaowei, et al.
Publicado: (2020)

Association between CYP2C19 and ABCB1 polymorphisms and clopidogrel resistance in clopidogrel-treated Chinese patients
por: Zhuo, Zhong-ling, et al.
Publicado: (2018)

The Potential of Single Nucleotide Polymorphisms (SNPs) as Biomarkers and Their Association with the Increased Risk of Coronary Heart Disease: A Systematic Review
por: Sitinjak, Bernap Dwi Putra, et al.
Publicado: (2023)

Targeting PIK3CG in Combination with Paclitaxel as a Potential Therapeutic Regimen in Claudin-Low Breast Cancer [Corrigendum]
Publicado: (2020)

Acute myocardial infarction occurring while on chronic clopidogrel therapy (‘clopidogrel failure’) is associated with high incidence of clopidogrel poor responsiveness and stent thrombosis
por: Regev, Ehud, et al.
Publicado: (2018)

Boosting platelet inhibition in poor responder to aspirin and clopidogrel undergoing percutaneous coronary intervention: role of tirofiban
por: Campo, Gianluca, et al.
Publicado: (2010)

Association of ABCC2 polymorphism with clopidogrel response in Chinese patients undergoing percutaneous coronary intervention
por: Chen, Lida, et al.
Publicado: (2022)

An updated analysis on the association of GSTM1 polymorphism and smoking exposure with the increased risk of coronary heart disease
por: Liu, Min, et al.
Publicado: (2022)

Clopidogrel Increases Dasabuvir Exposure With or Without Ritonavir, and Ritonavir Inhibits the Bioactivation of Clopidogrel
por: Itkonen, Matti K., et al.
Publicado: (2018)

Combination of cilostazol and clopidogrel attenuates Rat critical limb ischemia
por: Sheu, Jiunn-Jye, et al.
Publicado: (2012)

An Examination of Clopidogrel in the Treatment of Coronary Microvascular Disease
por: Iskandar, Nicholas P, et al.
Publicado: (2022)

Comparison of the effects of ticagrelor and clopidogrel on heart rate variability and heart rate turbulence in patients with percutaneous coronary interventions
por: Yagcioglu, Pinar, et al.
Publicado: (2020)

Association of CYP2C19 Polymorphism with Clopidogrel Resistance in Patients with Acute Coronary Syndrome in China
por: Su, Qiang, et al.
Publicado: (2019)

Association of ABCB1 Gene Polymorphisms and Clopidogrel Responsiveness in Iranian Patients undergoing Percutaneous Coronary Intervention
por: Namazi, Soha, et al.
Publicado: (2020)

Efficacy and safety of clopidogrel only vs. clopidogrel added proton pump inhibitors in the treatment of patients with coronary heart disease after percutaneous coronary intervention: A systematic review and meta-analysis
por: Pang, Jun, et al.
Publicado: (2019)

ABCB1 polymorphism in clopidogrel-treated Montenegrin patients
por: Mugosa, Snezana, et al.
Publicado: (2021)

Effects of Dual-Dose Clopidogrel, Clopidogrel Combined with Tongxinluo Capsule, and Ticagrelor on Patients with Coronary Heart Disease and CYP2C19*2 Gene Mutation After Percutaneous Coronary Interventions (PCI)
por: Chen, Shuxia, et al.
Publicado: (2017)

Determinants to optimize response to clopidogrel in acute coronary syndrome
por: Giusti, Betti, et al.
Publicado: (2010)

Effects of switching ticagrelor to clopidogrel on cardiovascular outcomes in patients with acute coronary syndrome
por: Liu, Lin, et al.
Publicado: (2018)

Influence of CYP450 Enzymes and ABCB1 Polymorphisms on Clopidogrel Response in Moroccan Patients with Acute Coronary Syndromes
por: Mouhrach, Ismail, et al.
Publicado: (2023)

Identification of PIK3CG as a hub in septic myocardial injury using network pharmacology and weighted gene co‐expression network analysis
por: Liu, Qiong, et al.
Publicado: (2022)

Clotrimazole Drug Resistance in Candida glabrata Clinical Isolates Correlates with Increased Expression of the Drug:H(+) Antiporters CgAqr1, CgTpo1_1, CgTpo3, and CgQdr2
por: Costa, Catarina, et al.
Publicado: (2016)

Analysis of the Reactivity of Aspirin and Clopidogrel and Its Influencing Factors in Patients with Coronary Heart Disease at High Altitude
por: Chang, Rong, et al.
Publicado: (2021)

Identification of single nucleotide polymorphisms of PIK3R1 and DUSP1 genes and their genetic associations with milk production traits in dairy cows
por: Han, Bo, et al.
Publicado: (2019)

Increased blood product use among coronary artery bypass patients prescribed preoperative aspirin and clopidogrel
por: Ray, Joel G, et al.
Publicado: (2003)

Clopidogrel Within Few Hours of Coronary Artery Bypass Grafting Does Significantly Increase the Risk of Bleeding
por: Hijazi, Emad M., et al.
Publicado: (2012)

The impact of CYP2C19 *2 and *3 polymorphism on clopidogrel response following coronary stenting in Saudi patients with acute coronary syndrome
por: H, Khalaf, et al.
Publicado: (2014)

cg04448376, cg24387542, cg08548498, and cg14621323 as a Novel Signature to Predict Prognosis in Kidney Renal Papillary Cell Carcinoma
por: Wang, Ying-Lei, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_nv84209aoeu6tj9oi5i2qrps12